Eledon Pharmaceuticals Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
ELDN Nasdaq 8731 https://eledon.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Eledon Pharmaceuticals Inc

Eledon Pharmaceuticals to Present at Jefferies Healthcare Conference - Jun 2nd, 2023 12:00 pm
Eledon Pharmaceuticals Reports First Quarter 2023 Operating and Financial Results - May 11th, 2023 8:01 pm
Eledon Pharmaceuticals to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023 - May 4th, 2023 8:05 pm
Eledon Pharmaceuticals Announces up to $185 Million Financing to Advance Tegoprubart Kidney Transplantation Clinical Trials - May 1st, 2023 11:00 am
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) Q4 2022 Earnings Call Transcript - Apr 5th, 2023 11:46 pm
Eledon Reports Data from Ongoing Phase 1b Trial Evaluating Tegoprubart in Patients Undergoing Kidney Transplantation at World Congress of Nephrology - Mar 31st, 2023 10:00 am
Eledon Pharmaceuticals Reports Fourth Quarter and Full-Year 2022 Operating and Financial Results - Mar 30th, 2023 8:01 pm
Eledon Pharmaceuticals to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, March 30, 2023 - Mar 23rd, 2023 8:05 pm
Eledon to Present Data from Ongoing Phase 1b Trial Evaluating Tegoprubart in Kidney Transplantation at the World Congress of Nephrology 2023 - Mar 23rd, 2023 12:00 pm
Eledon Pharmaceuticals to Present at SVB Securities Global Biopharma Conference - Feb 8th, 2023 9:05 pm
Eledon Pharmaceuticals Provides Business and Pipeline Updates - Jan 9th, 2023 1:31 pm
eGenesis and Eledon Pharmaceuticals Announce Collaboration for Use of Tegoprubart in Preclinical Xenotransplantation Studies - Jan 9th, 2023 1:30 pm
C-Path's Transplant Therapeutics Consortium Receives EMA Qualification Opinion for iBox Scoring System - Dec 21st, 2022 9:05 pm
Eledon Pharmaceuticals Reports Third Quarter 2022 Operating and Financial Results - Nov 14th, 2022 9:01 pm
Eledon Pharmaceuticals to Report Third Quarter 2022 Financial Results on Monday, November 14, 2022 - Nov 3rd, 2022 8:05 pm
Eledon Pharmaceuticals Announces Upcoming Presentations at ASN’s Kidney Week 2022 and NEALS - Oct 24th, 2022 8:05 pm
Eledon Pharmaceuticals to Participate in Two Upcoming Conferences - Oct 3rd, 2022 12:00 pm
Eledon Pharmaceuticals to Present at Ladenburg Thalmann Healthcare Conference - Sep 22nd, 2022 8:05 pm
Eledon Pharmaceuticals Receives FDA Clearance of IND Application to Evaluate Tegoprubart in IgA Nephropathy - Sep 6th, 2022 8:01 pm
Eledon Pharmaceuticals to Participate in Two Upcoming Investor Conferences - Aug 29th, 2022 12:00 pm